Previous 10 | Next 10 |
home / stock / wllw:cc / wllw:cc news
WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODS Canada NewsWire Program further validates Willow's technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation KA...
--News Direct-- Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share news the company has agreed to a Master Services Agreement with an innovative biotech company with the focus on age-related diseases. This partnership will see the company develop precision ...
WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES Canada NewsWire Biotech partner recognizes strength of Willow's first in class FutureGrown ™ technology platform for producing natural products ...
KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT Canada NewsWire Rapid success of first collaboration leads to partnership on high-value specialty ingredient Enzyme development expected to enable commercial-scale p...
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS Canada NewsWire MOUNTAIN VIEW, Calif. , May 12, 2023 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce...
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTS Canada NewsWire Starts off year with significant commercial momentum toward focus on delivering robust year-over-year revenue growth for 2023 Previous steps taken to further optimize Willow's business, focus on near...
WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONE Canada NewsWire Commercial agreement follows the early success on the development phase of the UDCA program with Sandhill One Solid execution on development phases leads to execution of agreement; illustrates comp...
WILLOW ANNOUNCES ROLLOUT OF BioOxi PLATFORM PROVIDING VALUABLE AND EXPEDITED BIOCONVERSION-ENABLED CHEMICAL MANUFACTURING Canada NewsWire Complements Company's significant expertise in existing strain engineering and precision fermentation Offers commer...
WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT Canada NewsWire Willow Continues its Transition to the Bay Area in California with Management Promotions and a New Board Member MOUNTAIN VIEW , Calif. , March 28, 2023 /CNW/ - Willow Bio...
WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAY WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLE...
News, Short Squeeze, Breakout and More Instantly...
Willow Biosciences Inc. Company Name:
WLLW:CC Stock Symbol:
TSXC Market:
Willow Biosciences Inc. Website:
WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITS Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ./ CALGARY, AB , July 18, 2024 /CNW/ - Willow Biosciences Inc. ...
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM Canada NewsWire Company announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients Company anticipates ...
--News Direct-- Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share the company's plans to raise approximately $3 million. This capital will be used to support Willow Bioscience's recent partnership announcement with Laurus Labs. Dr. Savile explained tha...